Disclosure: This site may earn affiliate commissions when you click provider links. This doesn't affect our recommendations. Learn more
Eden offers flat-rate, fast-start pricing. Found offers insurance checks and full coaching. Compare both to find the right GLP-1 program for you.
Eden and Found both offer compounded GLP-1 medications online, but they are built for very different people. Eden keeps the price simple: one all-inclusive rate at every dose, same-day consultations, and no coaching program layered on top (and, since September, no membership fee on its compounded medication either). Found goes the other direction: a full behavioral program, a free insurance coverage check, and access to more than ten different weight-loss medications, and its own compounded plan has since become a single bundled price rather than medication-plus-membership. If you're trying to decide between them, the choice usually comes down to one question: do you want the lowest flat-rate price, or do you want to maximize your chances of insurance covering as much as possible?
Answer 10 questions and get a personalized recommendation.
Take the free quiz โ| Eden | Found | |
|---|---|---|
| Starting price | $99/mo compounded semaglutide, $129/mo tirzepatide, all-in at every dose | $169/mo compounded plan (12-month prepay), medication included |
| Ongoing price | Same $99/mo sema, $129/mo tirzepatide, month to month, no membership (brand-name requires a $99/mo membership, $39 first month) | $169/mo (12-month) or $289/mo (month to month); $99โ$199/mo with qualifying insurance |
| Insurance support | No | Free coverage check included; PLUS pathway from $39/mo |
| Medications | Compounded sema, tirzepatide; brand Wegovy, Zepbound at cash-retail pricing | Compounded sema, tirzepatide, liraglutide; Foundayo, Wegovy, Zepbound, Mounjaro, Ozempic |
| Coaching | 24/7 care team messaging | Licensed clinicians, health coaches, behavior change app |
| Lab work required | No | Yes (at intake) |
| State availability | All 50 states | All 50 states |
| Best for | Self-pay, budget-conscious, flat pricing | Insurance users, those wanting structured support |
Eden positions itself as the no-friction option. You fill out a short intake form, get a same-day consultation, and can have medication shipped with free expedited delivery. Eden doesn't charge a membership fee on its compounded program: the medication price is the whole bill. That's a change since our last comparison (through September, Eden required a $99/month membership on top of the medication), and there's still no coaching program you pay for whether you use it or not. The membership now applies only to Eden's brand-name medications.
The most notable thing about Eden's pricing model is that the medication price doesn't change as your dose goes up. Most compounded semaglutide providers charge more at higher doses (a low starting price at 0.5mg can climb well past it at 2.4mg). Eden charges a flat, all-inclusive $99/month for compounded semaglutide and $129/month for tirzepatide regardless of dose. If you stay on medication long-term, that predictability can add up to real savings.
Eden offers compounded semaglutide and compounded tirzepatide, plus brand-name options including Wegovy, Zepbound, Ozempic, and Mounjaro for patients who qualify and prefer FDA-approved products. Those brand-name prices are Eden's own cash rate ($1,695/month for Wegovy, $1,399/month for Zepbound, Ozempic, and Mounjaro), each plus the $99/month membership, close to full retail rather than a discount off NovoCare or LillyDirect. Compounded medications contain the same active ingredient as their brand-name counterparts but are not FDA-approved as finished products and have not been evaluated in equivalent clinical trials.
The tradeoff is that Eden's intake is less thorough. No routine lab work is required before prescribing, which speeds up access but means less baseline clinical oversight compared to providers that require bloodwork upfront. Care team messaging is available 24/7, but there's no dedicated health coach or structured behavior change program.
Eden
$99/mo compounded semaglutide, $129/mo tirzepatide (all-in, no membership)
Flat all-in pricing at every dose, the lowest month-to-month compounded prices we track. Also offers brand Wegovy and Zepbound.
Found is built around the idea that weight management requires more than a prescription. The program includes licensed clinicians, personal health coaches, and a behavior change app, all of which are part of the membership. Found also runs a free insurance check on your behalf at enrollment, contacting your insurer to find out what's actually covered before you commit to a medication plan.
That insurance step matters more than it might seem. If your plan covers a brand-name GLP-1 like Wegovy or Zepbound with a manageable copay, Found can help you access it at a fraction of the self-pay price. If you're uninsured or your plan doesn't cover GLP-1s, Found also offers compounded semaglutide at cash-pay rates. Found's medication list is broader than most telehealth providers: more than ten options including compounded and brand-name GLP-1s, as well as non-GLP-1 weight-loss medications for patients who aren't candidates for semaglutide or tirzepatide.
The main complexity with Found is on the brand-name side. For compounded medication, Found now bundles everything into one price: $169/month on a 12-month prepaid plan, or $289/month month to month, medication included. For brand-name medication, a separate CORE membership is still charged on top of medication costs, and those costs vary significantly depending on your insurance situation; Found's pricing page no longer publishes exact per-dose brand rates, so you'll need to go through enrollment to get a clear picture of what you'd actually pay. For some patients, especially those with insurance coverage, that complexity resolves in their favor.
Found's compounded medications are not FDA-approved as finished products. Brand-name options offered through Found are FDA-approved and were evaluated in large randomized controlled trials: semaglutide 2.4mg (Wegovy) in the STEP 1 trial (NEJM, 2021) and tirzepatide (Zepbound) in the SURMOUNT-1 trial (NEJM, 2022).
Found
From $169/mo all-in (12-month compounded plan, medication included)
Free insurance check: find out what your plan covers before you start.
Eden's pricing is the easier one to explain. Compounded semaglutide is $99/month and compounded tirzepatide is $129/month, all-inclusive, with no membership fee and no first-month intro rate. The dose-independent structure means you pay the same in month three as you do in month twelve, regardless of what dose your provider has titrated you to. Eden says these are not introductory prices and advertises a lifetime price guarantee; check its terms for what that covers.
Found's compounded plan is also a single bundled price, $169/month on a 12-month plan or $289/month month to month, which makes it directly comparable. On cash price alone, Eden is cheaper: $70/month less for semaglutide and $40/month less for tirzepatide against Found's 12-month rate, and $160 to $190/month less month to month, with no year-long commitment. Both providers' prices reflect their own sites as re-verified in October 2026 and are subject to change. For brand-name medication, Found still layers a separate CORE membership on top of the medication cost, and those costs depend heavily on whether your insurance covers anything. If you're uninsured and comparing cash-pay options, check our guide to GLP-1 medications without insurance and the cheapest semaglutide options available in 2026 before assuming either provider is the better deal for your situation.
If you have insurance, Found's free coverage check is worth doing before you pay anything. Some commercial plans cover brand-name GLP-1s for patients who meet clinical criteria, which can bring the effective monthly cost down significantly. Our GLP-1 insurance coverage guide walks through how that process typically works.
Both providers offer compounded semaglutide and tirzepatide, the two active ingredients with the largest published evidence base for weight loss, studied in large randomized controlled trials (semaglutide in the STEP 1 trial, tirzepatide in the SURMOUNT-1 trial). Both also offer brand-name versions of those medications.
Eden's brand-name lineup: Wegovy, Zepbound, Ozempic, Mounjaro.
Found's brand-name lineup: Foundayo, Wegovy, Ozempic, Zepbound, Mounjaro, plus additional non-GLP-1 medications for patients who aren't appropriate candidates for injectable GLP-1 therapy.
The practical difference is Found's broader non-GLP-1 formulary. If a clinician determines during your intake that a GLP-1 isn't the right fit (due to a contraindication, prior GI issues, or personal preference), Found has more alternatives to offer. Eden's path runs almost exclusively through GLP-1s.
Pros
Cons
Eden keeps support minimal by design. You have 24/7 access to a care team via messaging, so questions about side effects or titration schedules can get answered. But there's no health coach, no structured program, no app tracking your habits. For people who've done their research and just want a prescription and a reliable supply, that's a feature, not a bug.
Found is different in kind, not just in degree. The membership includes licensed clinicians who handle your prescription, plus dedicated health coaches who work with you on the behavioral side of weight management: sleep, stress, eating patterns, exercise. There's also a companion app for tracking and habit building. Whether that level of support moves the needle for you depends on what's worked (or hasn't) in the past.
The clinical evidence on behavioral support combined with medication is generally positive. Studies suggest that structured lifestyle intervention alongside GLP-1 therapy may improve outcomes compared to medication alone (NEJM, 2021, STEP 3 trial). Whether Found's specific program delivers on that promise is harder to evaluate independently, but for patients who want accountability built into their program, it's the more complete option.
Eden is the right call if most of these apply to you. As with any prescription medication, discuss your health history and goals with a licensed clinician before starting.
You're paying out of pocket and want to know exactly what you'll spend each month. You want to start quickly without a lengthy intake process. You've already done your research on GLP-1 medications and aren't looking for intensive hand-holding. You're primarily interested in compounded semaglutide or tirzepatide and don't need access to non-GLP-1 alternatives. You're comfortable with less clinical structure in exchange for lower cost and faster access.
The flat-rate model is genuinely useful for long-term planning. Knowing your cost won't increase as your dose does makes budgeting straightforward in a way that variable-dose pricing doesn't. And on compounded medication, Eden's month-to-month price is lower than Found's 12-month rate.
Visit Eden's provider page for the full breakdown of their program.
Found makes more sense if you have health insurance and want to find out whether any of it applies to GLP-1 medications. The free insurance check is a legitimate differentiator: it takes something most patients would have to figure out on their own and handles it for you. If your plan covers Wegovy or Zepbound, Found may end up being significantly cheaper than any compounded option.
Found also fits people who want the behavioral structure (the coaching, the app, the accountability framework) and are willing to pay for it as part of a comprehensive program. If previous attempts at weight management haven't worked without that kind of support, a more structured program is worth considering.
One more case where Found wins: if you have a contraindication to GLP-1s or need to explore alternatives, their broader formulary gives clinicians more options.
Visit Found's provider page for the full breakdown of their program.
These two providers are genuinely different products. Eden is fast, flat-priced, and now the cheaper of the two by a clear margin, built for self-pay patients who want predictable access to compounded GLP-1s: with its compounded membership gone, $99 or $129/month is the whole bill. Found's compounded plan is just as transparently priced ($169 to $289/month, bundled) but costs more, while its brand-name pricing is the piece that's slower to nail down and potentially cheaper for insured patients. Found remains meaningfully more supportive for people who want coaching alongside their prescription.
If you're uninsured, paying cash, and want to start this week, Eden is the easier choice. If you have insurance and haven't checked whether it covers GLP-1s, go through Found's enrollment first: you might be surprised what's available. And if the behavioral program matters to you, Found is the only one of these two that offers it.
Still not sure which provider fits your situation? The RxPickr GLP-1 quiz takes about two minutes and factors in your insurance status, budget, medication preferences, and more.